[2-[[(4R)-4-furo[3,2-b]pyridin-2-yl-2,5-dioxo-1-(2-trimethylsilylethoxymethyl)imidazolidin-4-yl]methyl]-3-oxo-1H-isoindol-5-yl] trifluoromethanesulfonate;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;methylsulfonyl trifluoromethanesulfonate;2,4,6-trimethyl-1,3,5,2,4,6-trioxatriborinane

C121H127B3F6N20O36S3Si3 — CID 160682405

IUPAC[2-[[(4R)-4-furo[3,2-b]pyridin-2-yl-2,5-dioxo-1-(2-trimethylsilylethoxymethyl)imidazolidin-4-yl]methyl]-3-oxo-1H-isoindol-5-yl] trifluoromethanesulfonate;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;methylsulfonyl trifluoromethanesulfonate;2,4,6-trimethyl-1,3,5,2,4,6-trioxatriborinane
SMILESCB1OB(C)OB(C)O1.CS(=O)(=O)OS(=O)(=O)C(F)(F)F.C[Si](C)(C)CCOCN1C(=O)N[C@](CN2Cc3ccc(O)cc3C2=O)(c2cc3ncccc3o2)C1=O.C[Si](C)(C)CCOCN1C(=O)N[C@](CN2Cc3ccc(OS(=O)(=O)C(F)(F)F)cc3C2=O)(c2cc3ncccc3o2)C1=O.Cc1ccc2c(c1)C(=O)N(C[C@]1(c3cc4ncccc4o3)NC(=O)N(COCC[Si](C)(C)C)C1=O)C2.Cc1ccc2c(c1)C(=O)N(C[C@]1(c3cc4ncccc4o3)NC(=O)NC1=O)C2.O=C1NC(=O)[C@@](CN2Cc3ccc(O)cc3C2=O)(c2cc3ncccc3o2)N1
InChIInChI=1S/C26H27F3N4O8SSi.C26H30N4O5Si.C25H28N4O6Si.C20H16N4O4.C19H14N4O5.C3H9B3O3.C2H3F3O5S2/c1-43(2,3)10-9-39-15-33-23(35)25(31-24(33)36,21-12-19-20(40-21)5-4-8-30-19)14-32-13-16-6-7-17(11-18(16)22(32)34)41-42(37,38)26(27,28)29;1-17-7-8-18-14-29(23(31)19(18)12-17)15-26(22-13-20-21(35-22)6-5-9-27-20)24(32)30(25(33)28-26)16-34-10-11-36(2,3)4;1-36(2,3)10-9-34-15-29-23(32)25(27-24(29)33,21-12-19-20(35-21)5-4-8-26-19)14-28-13-16-6-7-17(30)11-18(16)22(28)31;1-11-4-5-12-9-24(17(25)13(12)7-11)10-20(18(26)22-19(27)23-20)16-8-14-15(28-16)3-2-6-21-14;24-11-4-3-10-8-23(16(25)12(10)6-11)9-19(17(26)21-18(27)22-19)15-7-13-14(28-15)2-1-5-20-13;1-4-7-5(2)9-6(3)8-4;1-11(6,7)10-12(8,9)2(3,4)5/h4-8,11-12H,9-10,13-15H2,1-3H3,(H,31,36);5-9,12-13H,10-11,14-16H2,1-4H3,(H,28,33);4-8,11-12,30H,9-10,13-15H2,1-3H3,(H,27,33);2-8H,9-10H2,1H3,(H2,22,23,26,27);1-7,24H,8-9H2,(H2,21,22,26,27);1-3H3;1H3/t25-;26-;25-;20-;19-;;/m11111../s1
InChIKeyROHXLJUJFUVAHZ-VQGMZFJKSA-N
MW2764.33 g/mol
LogP14.14
Rot. Bonds34

About [2-[[(4R)-4-furo[3,2-b]pyridin-2-yl-2,5-dioxo-1-(2-trimethylsilylethoxymethyl)imidazolidin-4-yl]methyl]-3-oxo-1H-isoindol-5-yl] trifluoromethanesulfonate;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;methylsulfonyl trifluoromethanesulfonate;2,4,6-trimethyl-1,3,5,2,4,6-trioxatriborinane

[2-[[(4R)-4-furo[3,2-b]pyridin-2-yl-2,5-dioxo-1-(2-trimethylsilylethoxymethyl)imidazolidin-4-yl]methyl]-3-oxo-1H-isoindol-5-yl] trifluoromethanesulfonate;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;methylsulfonyl trifluoromethanesulfonate;2,4,6-trimethyl-1,3,5,2,4,6-trioxatriborinane (PubChem CID 160682405) has the molecular formula C121H127B3F6N20O36S3Si3 and a molecular weight of 2764.33 g/mol. Its IUPAC name is [2-[[(4R)-4-furo[3,2-b]pyridin-2-yl-2,5-dioxo-1-(2-trimethylsilylethoxymethyl)imidazolidin-4-yl]methyl]-3-oxo-1H-isoindol-5-yl] trifluoromethanesulfonate;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;methylsulfonyl trifluoromethanesulfonate;2,4,6-trimethyl-1,3,5,2,4,6-trioxatriborinane.

Molecular Properties

Compound Name[2-[[(4R)-4-furo[3,2-b]pyridin-2-yl-2,5-dioxo-1-(2-trimethylsilylethoxymethyl)imidazolidin-4-yl]methyl]-3-oxo-1H-isoindol-5-yl] trifluoromethanesulfonate;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;methylsulfonyl trifluoromethanesulfonate;2,4,6-trimethyl-1,3,5,2,4,6-trioxatriborinane
PubChem CID160682405
Molecular FormulaC121H127B3F6N20O36S3Si3
Molecular Weight2764.33 g/mol
Exact Mass2762.74
IUPAC Name[2-[[(4R)-4-furo[3,2-b]pyridin-2-yl-2,5-dioxo-1-(2-trimethylsilylethoxymethyl)imidazolidin-4-yl]methyl]-3-oxo-1H-isoindol-5-yl] trifluoromethanesulfonate;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;methylsulfonyl trifluoromethanesulfonate;2,4,6-trimethyl-1,3,5,2,4,6-trioxatriborinane
SMILESCB1OB(C)OB(C)O1.CS(=O)(=O)OS(=O)(=O)C(F)(F)F.C[Si](C)(C)CCOCN1C(=O)N[C@](CN2Cc3ccc(O)cc3C2=O)(c2cc3ncccc3o2)C1=O.C[Si](C)(C)CCOCN1C(=O)N[C@](CN2Cc3ccc(OS(=O)(=O)C(F)(F)F)cc3C2=O)(c2cc3ncccc3o2)C1=O.Cc1ccc2c(c1)C(=O)N(C[C@]1(c3cc4ncccc4o3)NC(=O)N(COCC[Si](C)(C)C)C1=O)C2.Cc1ccc2c(c1)C(=O)N(C[C@]1(c3cc4ncccc4o3)NC(=O)NC1=O)C2.O=C1NC(=O)[C@@](CN2Cc3ccc(O)cc3C2=O)(c2cc3ncccc3o2)N1
InChIInChI=1S/C26H27F3N4O8SSi.C26H30N4O5Si.C25H28N4O6Si.C20H16N4O4.C19H14N4O5.C3H9B3O3.C2H3F3O5S2/c1-43(2,3)10-9-39-15-33-23(35)25(31-24(33)36,21-12-19-20(40-21)5-4-8-30-19)14-32-13-16-6-7-17(11-18(16)22(32)34)41-42(37,38)26(27,28)29;1-17-7-8-18-14-29(23(31)19(18)12-17)15-26(22-13-20-21(35-22)6-5-9-27-20)24(32)30(25(33)28-26)16-34-10-11-36(2,3)4;1-36(2,3)10-9-34-15-29-23(32)25(27-24(29)33,21-12-19-20(35-21)5-4-8-26-19)14-28-13-16-6-7-17(30)11-18(16)22(28)31;1-11-4-5-12-9-24(17(25)13(12)7-11)10-20(18(26)22-19(27)23-20)16-8-14-15(28-16)3-2-6-21-14;24-11-4-3-10-8-23(16(25)12(10)6-11)9-19(17(26)21-18(27)22-19)15-7-13-14(28-15)2-1-5-20-13;1-4-7-5(2)9-6(3)8-4;1-11(6,7)10-12(8,9)2(3,4)5/h4-8,11-12H,9-10,13-15H2,1-3H3,(H,31,36);5-9,12-13H,10-11,14-16H2,1-4H3,(H,28,33);4-8,11-12,30H,9-10,13-15H2,1-3H3,(H,27,33);2-8H,9-10H2,1H3,(H2,22,23,26,27);1-7,24H,8-9H2,(H2,21,22,26,27);1-3H3;1H3/t25-;26-;25-;20-;19-;;/m11111../s1
InChIKeyROHXLJUJFUVAHZ-VQGMZFJKSA-N
XLogP14.14
TPSA713.05 Ų
H-Bond Donors9
H-Bond Acceptors41
Rotatable Bonds34
Heavy Atoms192
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002764.33
LogP ≤ 514.14
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1041

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'hydantoin', 'substructure': 'N/A'}, {'alert_name': 'Sulfonic_acid_1', 'substructure': 'N/A'}, {'alert_name': 'triflate', 'substructure': 'N/A'}

Analyze [2-[[(4R)-4-furo[3,2-b]pyridin-2-yl-2,5-dioxo-1-(2-trimethylsilylethoxymethyl)imidazolidin-4-yl]methyl]-3-oxo-1H-isoindol-5-yl] trifluoromethanesulfonate;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;methylsulfonyl trifluoromethanesulfonate;2,4,6-trimethyl-1,3,5,2,4,6-trioxatriborinane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [2-[[(4R)-4-furo[3,2-b]pyridin-2-yl-2,5-dioxo-1-(2-trimethylsilylethoxymethyl)imidazolidin-4-yl]methyl]-3-oxo-1H-isoindol-5-yl] trifluoromethanesulfonate;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;methylsulfonyl trifluoromethanesulfonate;2,4,6-trimethyl-1,3,5,2,4,6-trioxatriborinane?
The IUPAC name of [2-[[(4R)-4-furo[3,2-b]pyridin-2-yl-2,5-dioxo-1-(2-trimethylsilylethoxymethyl)imidazolidin-4-yl]methyl]-3-oxo-1H-isoindol-5-yl] trifluoromethanesulfonate;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;methylsulfonyl trifluoromethanesulfonate;2,4,6-trimethyl-1,3,5,2,4,6-trioxatriborinane (CID 160682405) is [2-[[(4R)-4-furo[3,2-b]pyridin-2-yl-2,5-dioxo-1-(2-trimethylsilylethoxymethyl)imidazolidin-4-yl]methyl]-3-oxo-1H-isoindol-5-yl] trifluoromethanesulfonate;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;methylsulfonyl trifluoromethanesulfonate;2,4,6-trimethyl-1,3,5,2,4,6-trioxatriborinane.
What is the SMILES notation for [2-[[(4R)-4-furo[3,2-b]pyridin-2-yl-2,5-dioxo-1-(2-trimethylsilylethoxymethyl)imidazolidin-4-yl]methyl]-3-oxo-1H-isoindol-5-yl] trifluoromethanesulfonate;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;methylsulfonyl trifluoromethanesulfonate;2,4,6-trimethyl-1,3,5,2,4,6-trioxatriborinane?
The canonical SMILES for [2-[[(4R)-4-furo[3,2-b]pyridin-2-yl-2,5-dioxo-1-(2-trimethylsilylethoxymethyl)imidazolidin-4-yl]methyl]-3-oxo-1H-isoindol-5-yl] trifluoromethanesulfonate;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;methylsulfonyl trifluoromethanesulfonate;2,4,6-trimethyl-1,3,5,2,4,6-trioxatriborinane is CB1OB(C)OB(C)O1.CS(=O)(=O)OS(=O)(=O)C(F)(F)F.C[Si](C)(C)CCOCN1C(=O)N[C@](CN2Cc3ccc(O)cc3C2=O)(c2cc3ncccc3o2)C1=O.C[Si](C)(C)CCOCN1C(=O)N[C@](CN2Cc3ccc(OS(=O)(=O)C(F)(F)F)cc3C2=O)(c2cc3ncccc3o2)C1=O.Cc1ccc2c(c1)C(=O)N(C[C@]1(c3cc4ncccc4o3)NC(=O)N(COCC[Si](C)(C)C)C1=O)C2.Cc1ccc2c(c1)C(=O)N(C[C@]1(c3cc4ncccc4o3)NC(=O)NC1=O)C2.O=C1NC(=O)[C@@](CN2Cc3ccc(O)cc3C2=O)(c2cc3ncccc3o2)N1.
What is the InChIKey of [2-[[(4R)-4-furo[3,2-b]pyridin-2-yl-2,5-dioxo-1-(2-trimethylsilylethoxymethyl)imidazolidin-4-yl]methyl]-3-oxo-1H-isoindol-5-yl] trifluoromethanesulfonate;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;methylsulfonyl trifluoromethanesulfonate;2,4,6-trimethyl-1,3,5,2,4,6-trioxatriborinane?
The InChIKey is ROHXLJUJFUVAHZ-VQGMZFJKSA-N. The full InChI is InChI=1S/C26H27F3N4O8SSi.C26H30N4O5Si.C25H28N4O6Si.C20H16N4O4.C19H14N4O5.C3H9B3O3.C2H3F3O5S2/c1-43(2,3)10-9-39-15-33-23(35)25(31-24(33)36,21-12-19-20(40-21)5-4-8-30-19)14-32-13-16-6-7-17(11-18(16)22(32)34)41-42(37,38)26(27,28)29;1-17-7-8-18-14-29(23(31)19(18)12-17)15-26(22-13-20-21(35-22)6-5-9-27-20)24(32)30(25(33)28-26)16-34-10-11-36(2,3)4;1-36(2,3)10-9-34-15-29-23(32)25(27-24(29)33,21-12-19-20(35-21)5-4-8-26-19)14-28-13-16-6-7-17(30)11-18(16)22(28)31;1-11-4-5-12-9-24(17(25)13(12)7-11)10-20(18(26)22-19(27)23-20)16-8-14-15(28-16)3-2-6-21-14;24-11-4-3-10-8-23(16(25)12(10)6-11)9-19(17(26)21-18(27)22-19)15-7-13-14(28-15)2-1-5-20-13;1-4-7-5(2)9-6(3)8-4;1-11(6,7)10-12(8,9)2(3,4)5/h4-8,11-12H,9-10,13-15H2,1-3H3,(H,31,36);5-9,12-13H,10-11,14-16H2,1-4H3,(H,28,33);4-8,11-12,30H,9-10,13-15H2,1-3H3,(H,27,33);2-8H,9-10H2,1H3,(H2,22,23,26,27);1-7,24H,8-9H2,(H2,21,22,26,27);1-3H3;1H3/t25-;26-;25-;20-;19-;;/m11111../s1.
What are the key properties of [2-[[(4R)-4-furo[3,2-b]pyridin-2-yl-2,5-dioxo-1-(2-trimethylsilylethoxymethyl)imidazolidin-4-yl]methyl]-3-oxo-1H-isoindol-5-yl] trifluoromethanesulfonate;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;methylsulfonyl trifluoromethanesulfonate;2,4,6-trimethyl-1,3,5,2,4,6-trioxatriborinane?
[2-[[(4R)-4-furo[3,2-b]pyridin-2-yl-2,5-dioxo-1-(2-trimethylsilylethoxymethyl)imidazolidin-4-yl]methyl]-3-oxo-1H-isoindol-5-yl] trifluoromethanesulfonate;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;methylsulfonyl trifluoromethanesulfonate;2,4,6-trimethyl-1,3,5,2,4,6-trioxatriborinane has a molecular weight of 2764.33 g/mol, XLogP of 14.14, 34 rotatable bonds, 9 hydrogen bond donors, and 41 hydrogen bond acceptors.
Where does this data come from?
All data for [2-[[(4R)-4-furo[3,2-b]pyridin-2-yl-2,5-dioxo-1-(2-trimethylsilylethoxymethyl)imidazolidin-4-yl]methyl]-3-oxo-1H-isoindol-5-yl] trifluoromethanesulfonate;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-furo[3,2-b]pyridin-2-yl-5-[(5-methyl-3-oxo-1H-isoindol-2-yl)methyl]-3-(2-trimethylsilylethoxymethyl)imidazolidine-2,4-dione;methylsulfonyl trifluoromethanesulfonate;2,4,6-trimethyl-1,3,5,2,4,6-trioxatriborinane is sourced from PubChem (CID 160682405), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).